Production (Stage)
Harmony Biosciences Holdings, Inc.
HRMY
$35.14
-$0.71-1.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.91% | 12.91% | -18.66% | -42.57% | -27.32% |
| Total Depreciation and Amortization | -1.90% | -1.01% | -0.14% | 0.61% | 0.70% |
| Total Amortization of Deferred Charges | -66.34% | -69.22% | -71.49% | 6.55% | 22.26% |
| Total Other Non-Cash Items | 77.09% | 96.90% | 220.49% | 206.22% | 154.40% |
| Change in Net Operating Assets | -217.24% | -120.90% | 129.97% | 3,295.19% | 246.92% |
| Cash from Operations | 7.07% | 0.20% | 30.42% | 32.21% | 31.48% |
| Capital Expenditure | -302.52% | -269.55% | -264.39% | -155.67% | -149.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 10.54% | 10.54% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.47% | -263.12% | 55.17% | 69.37% | 86.90% |
| Cash from Investing | -15.94% | -45.32% | -68.26% | -10.14% | 50.92% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 92.67% | 92.55% | 92.42% | -10,287.50% | -10,125.00% |
| Issuance of Common Stock | 778.84% | 28.61% | -56.29% | -88.73% | -88.39% |
| Repurchase of Common Stock | 96.21% | 97.52% | 0.49% | -19,407.59% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 93.15% | 89.58% | -25.13% | -1,587.55% | -1,369.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 250.29% | 109.72% | 0.04% | -100.12% | -29.82% |